Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD, discuss the use of beta-blocker therapy following acute MI ...

The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study ...

THIS study consists of detailed clinical observations on 100 consecutive cases of acute myocardial infarction at St. Luke's Hospital, New York City. Eighty-five of these patients were observed ...

The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study ...

A shift in the beta-blocker treatment paradigm has arrived with the changing myocardial infarction treatment landscape, said ...

Percutaneous coronary intervention (PCI) has proven lifesaving: Morbidity and mortality outcomes are significantly improved ...

The following is a summary of “Healthcare Resource Utilization Following Acute Myocardial Infarction Findings from RECORD-MI ...

EMPACT-MI trial (EMPAgliflozin for the prevention of Chronic heart failure and morTality after an acute Myocardial Infarction, NCT04509674) is a multicenter, randomized, parallel-group, double ...

At the lesion level, very intensive lipid-lowering therapy induced substantially greater percent atheroma volume regression than described in previous vessel-level analyses. Compared with statin ...

Background In acute heart failure (HF), reduced cardiac output, vasoconstriction and congestion may damage the intestinal ...

Several firms are bringing high-sensitivity cardiac troponin testing into the ER, although doctors are not yet certain how ...

Classical symptoms of acute myocardial infarction include sudden chest pain (typically radiating to the left arm or left side of the neck), shortness of breath, nausea, vomiting, palpitations ...